Posted by Clinical Lab Products | Jan 8, 2006 | Cancer, Miscellaneous |
Imagine being told that you have invasive cancer, undergoing radical surgery and radiation treatment, and then finding out that your lab results had been switched and you never had cancer. It happened to a woman from Ohio, and allegations of s
Read MorePosted by Clinical Lab Products | Jan 7, 2006 | Middleware & Software, Miscellaneous |
AutoMate6 software has enabled users at Pacific Toxicology Laboratories to automate a variety of time-consuming tasks. Many California laboratories are investing in enhanced automation software to slash costs, streamline information flow, an
Read MorePosted by Clinical Lab Products | Jan 6, 2006 | Miscellaneous |
Keeping an eye on the big picture can be difficult when you’re in the frame, but in health care it’s a common way to operate, which explains why point-of-care testing (POCT) has become so prevalent despite the high costs to the lab. I
Read MorePosted by Clinical Lab Products | Jan 2, 2006 | Cancer, Miscellaneous |
Pharmaceutical giants Merck & Co. and GlaxoSmithKline are racing to the marketplace with a vaccine to prevent cervical cancer. Both vaccines prevent early stage cervical cancer and precancerous lesions caused by human papillomavirus (HPV)
Read MorePosted by Clinical Lab Products | Dec 5, 2005 | Miscellaneous |
By Michelle Said An Interview With Eric Bouvier, president & CEO, North America Eric Bouvier The seeds of in vitro diagnostic specialty company bioMérieux were planted when Louis Pasteur’s assistant, Marcel Mérieux, founded Institut Mé
Read More